Clinical Trial Update: Safety and Efficacy Study of Idarubicin Dose Intensification to Treat Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 clinical trial evaluating intensified dosing of idarubicin for acute myeloid leukemia to assess safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Idarubicin (idarubicin)

Snippet

Sponsor: Konkuk University Medical Center | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED